March Continues 2025’s Sluggish Start, Dipping 16% In Deal Volume
The 2025 healthcare M&A market is off to a slow start, based on preliminary results for the first three months. Continuing to dip from the 223 announced in January 2025, there have been 126 transactions reported, to date, in March, according to data captured in the LevinPro HC database. This is on par with the 124 transactions reported in February 2025. However, March represents a 16% drop from the 150 in March 2024. Additionally, March brings Q1:25’s total deal volume to 482 transactions, representing a 6% decline from 511 transactions announced during Q1:24. The most active sector was Physician Medical Groups (PMG) with 36 recorded deals for March. It is not surprising that PMG had... Read More »
Addus 2024 Earnings: Growth Stumbles Amid Debt and Integration Woes
On February 24, 2025, Addus HomeCare Corporation, a leading provider of home-based personal care, nursing and rehabilitative therapy services, released its financial results for the fourth quarter and full year (FY) ended December 31, 2024, after the market close. The results? Not terrible, but don’t break out the champagne either. Addus Q4 and FY 2024 Financial Snapshot: Metric Q4 2024 Q4 2023 FY 2024 FY 2023 Revenue $297.1 million $276.4 million $1.15 billion $1.06 billion Net Income $19.5 million $19.6 million $73.6 million $62.5 million Net Income per Diluted... Read More »
DOGE Finds $2.7 Trillion in Improper Payments: Healthcare’s Wake-Up Call
The Department of Government Efficiency (DOGE) revealed during a DOGE subcommittee hearing on February 12 that since 2003, the U.S. government has issued $2.7 trillion in improper payments across various federal agencies, including Medicare and Medicaid. While a precise breakdown for these programs was not provided, Medicare and Medicaid have consistently been a source of improper payments among federal programs, raising concerns about the long-term security of federal healthcare spending. In 2023 alone, the Department of Health and Human Services (HHS) reported approximately $100 billion in improper payments tied to Medicare and Medicaid. A critical area of concern lies within the durable... Read More »
Exploring the MedSpa M&A Market: Trends, Drivers and 2025 Outlook
Medical spas, or MedSpas, are hybrid establishments combining the luxury of a traditional spa with medical-grade aesthetic procedures. As an intersection of health, beauty and medicine, MedSpas have seen a surge in popularity in recent years. As wellness and aesthetic care continue to gain prominence in the daily lives of millions, the medical spa sector has become a focal point for M&A, reflecting a robust market landscape poised for further growth. The MedSpa sector’s prominence was evident at various healthcare conferences attended by the LevinPro HC team in 2024. During McGuireWoods’ 17th Annual Healthcare Finance and Growth Conference in September 2024, Eugene Goldenberg of... Read More »
PwC’s Behind the Numbers of Medical Costs
PwC’s Health Research Institute published an article in early January 2025 that projects commercial healthcare spending growth will hit a 13-year high in 2025, with an 8% increase in the Group market and 7.5% in the Individual market. This is driven by inflation, the rising cost of prescription drugs and increased behavioral health utilization. Updated 2023 and 2024 trends reveal higher-than-expected costs due to increased use of GLP-1 drugs and deferred pandemic care. While cost-saving measures like biosimilars offer some relief, they do not counter the increasing expenses. The report highlights the need for healthcare organizations to develop strategies that balance cost... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
